Allarity Therapeutics Makes Strategic Pivot to Focus Solely on[...]
Allarity Therapeutics Announces 1 for 20 Reverse Stock Split
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain[...]
08/11/2022 | Press release | Distributed by Public on 08/11/2022 00:04
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact